Pharmaron Investments, Amgen Ventures and MRL Ventures Fund helped the bone marrow cancer drug developer double its total funding to about $160m.

LBO France’s Digital Health 2, which has a targeted close of about $240m, has secured Orange and its Enovacom subsidiary as a limited partner.

The digital healthcare platform developer secured $32.4m from investors including Apotek Hjärtat, which acquired a 42% stake two years ago.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The $77.1m Sumisei Innovation Fund will run for a decade and back insurtech and healthtech developers, having partnered SBI Investment to identify investment opportunities.

Harvard University’s Wyss Institute has partnered Northpond Labs to create a research and innovation alliance equipped with $12m in funding.

The property developer has backed Chinese Academy of Medical Sciences spinout Juventas to help advance its clinical-stage oncology cell therapy candidates.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

GlaxoSmithKline's corporate venturing unit is now an independent firm with a $500m fund anchored by its former parent.

MPM Capital and Qiming Venture Partners USA have co-led a series A round for Umoja Biopharma, based on research at Purdue University and Seattle Children’s Research Institute.